Abbott nutritionals
This article was originally published in The Tan Sheet
Executive Summary
Firm's Ross division experienced double-digit growth in both pediatric and adult nutritional segments, with overall sales increasing 8.7% to $520 mil. in the second quarter. Abbott's infant formula business grew 12% on the strength of Similac Advance, while adult nutritionals were boosted by strong incremental sales of ZonePerfect and 20% growth in the Glucerna line. The firm expects the division to grow in the high single-digits in the second half of 2004. Abbott reported overall worldwide sales of $4.7 bil., up 14% over the prior-year period...
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.